We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ranbaxy Wins Lipitor Patent Case In Austria; Pfizer to Appeal
Ranbaxy Wins Lipitor Patent Case In Austria; Pfizer to Appeal
April 5, 2005
Indian drugmaker Ranbaxy Pharmaceuticals scored a victory on the patent front last month when the Austrian Patent Office (APO) invalidated a patent on Pfizer’s cholesterol-lowering drug Lipitor.